205 related articles for article (PubMed ID: 18788403)
1. [Management of chronic kidney disease--preventing the progression of renal disease].
Kuroki A; Akizawa T
Nihon Rinsho; 2008 Sep; 66(9):1735-40. PubMed ID: 18788403
[TBL] [Abstract][Full Text] [Related]
2. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
3. Which antihypertensive drugs are the most nephroprotective and why?
Cravedi P; Ruggenenti P; Remuzzi G
Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
[TBL] [Abstract][Full Text] [Related]
4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
5. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
6. [Nephroprotection: how to slow the progression of chronic renal insufficiency?].
Hannedouche T; Krummel T; Parvez-Braun L
Nephrol Ther; 2005 May; 1(2):135-44. PubMed ID: 16895678
[TBL] [Abstract][Full Text] [Related]
7. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
Takeda T; Gejyo F
Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
Garini G; Allegri L; Arisi L
Ann Ital Med Int; 1989; 4(3):184-94. PubMed ID: 2702030
[TBL] [Abstract][Full Text] [Related]
9. Progression of chronic renal disease.
Klahr S
Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
[TBL] [Abstract][Full Text] [Related]
10. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
Griffin KA; Bidani AK
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
[TBL] [Abstract][Full Text] [Related]
11. [Lifestyle interventions for the management of early stage of chronic kidney disease].
Matsumoto H; Nakao T
Nihon Rinsho; 2008 Sep; 66(9):1799-802. PubMed ID: 18788412
[TBL] [Abstract][Full Text] [Related]
12. [Ways to inhibit development of chronic renal failure].
Tareeva IE; Kutyrina IM; Nikolaev AIu; Lifshits NL; Shvetsov MIu
Ter Arkh; 2000; 72(6):9-14. PubMed ID: 10900641
[No Abstract] [Full Text] [Related]
13. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
Tislér A
Orv Hetil; 2003 May; 144(18 Suppl 1):898-901. PubMed ID: 12785234
[TBL] [Abstract][Full Text] [Related]
14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
Hollenberg NK; Raij L
Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
[TBL] [Abstract][Full Text] [Related]
16. Achieving maximal renal protection in nondiabetic chronic renal disease.
Taal MW; Brenner BM
Am J Kidney Dis; 2001 Dec; 38(6):1365-71. PubMed ID: 11728976
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
Maione A; Strippoli GF
Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
[TBL] [Abstract][Full Text] [Related]
18. [Management of hypertension in CKD patients].
Kusaba T; Kimura K
Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
[TBL] [Abstract][Full Text] [Related]
19. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
